BGIM
GMAB icon

Brandywine Global Investment Management’s Genmab GMAB Stock Holding History

Brandywine Global Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$31.8M Sell
1,031,464
-381,371
-27% -$11.9M 0.21% 122
2025
Q3 		$43.3M Sell
1,412,835
-331,934
-19% -$8.09M 0.3% 98
2025
Q2 		$36M Buy
1,744,769
+27,372
+2% +$562K 0.25% 110
2025
Q1 		$33.6M Buy
1,717,397
+97,633
+6% +$2.05M 0.24% 113
2024
Q4 		$33.8M Buy
+1,619,764
New +$35.6M 0.25% 103

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brandywine Global Investment Management's GMAB Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its Genmab (GMAB) stake by 27% in Q4 2025, selling an estimated $11.9M and leaving 1,031,464 shares worth $31.8M. The position accounts for 0.21% of the portfolio, ranked #122.

Brandywine Global Investment Management first reported a position in GMAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $43.3M in Q3 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • Brandywine Global Investment Management held 1,031,464 shares of Genmab worth $31.8M as of Q4 2025.
  • Brandywine Global Investment Management sold 381,371 Genmab shares in Q4 2025, an estimated $11.9M.
  • Genmab made up 0.21% of Brandywine Global Investment Management's portfolio in Q4 2025, its #122 holding.
  • Brandywine Global Investment Management first reported a position in Genmab in Q4 2024 and has held it in 5 quarters since.
  • Brandywine Global Investment Management's Genmab position peaked at $43.3M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.